neobookRx
GuidelinesOther guideline

References

Mallol J, Crane J, Von Mutius E, et al. The International Study of Asthma and Allergies in Childhood (ISAAC) phase three: A global synthesis. Allergol Immunopathol (Madr). 2013;41(2):73–85. https://doi.org/10.1016/j.aller.2012.03.001 Zar HJ, Ehrlich RI, Workman L, Weinberg EG. The changing prevalence of asthma, allergic rhinitis and atopic eczema in African adolescents from 1995 to 2002. Pediatr

  1. Mallol J, Crane J, Von Mutius E, et al. The International Study of Asthma and Allergies in Childhood (ISAAC) phase three: A global synthesis. Allergol Immunopathol (Madr). 2013;41(2):73–85. https://doi.org/10.1016/j.aller.2012.03.001
  2. Zar HJ, Ehrlich RI, Workman L, Weinberg EG. The changing prevalence of asthma, allergic rhinitis and atopic eczema in African adolescents from 1995 to 2002. Pediatr Allergy Immunol. 2007;18(7):560–565. https://doi.org/10.1111/j. 1399- 3038.2007.00554.x
  3. Singh K, Axelrod S, Bielory L. The epidemiology of ocular and nasal allergy in the United States, 1988–1994. J Allergy Clin Immunol. 2010;126(4):778–783. https://doi.org/10.1016/j.jaci.2010.06.050
  4. Seedat RY, Sujee M, Ismail W, et al. Allergic rhinitis in medical students at the University of the Free State. S Afr Fam Prac. 2018;60(4):121–125. https://doi.org/10.1080/20786190.2018.1437869
  5. Bauchau V. Prevalence and rate of diagnosis of allergic rhinitis in Europe. Eur Respir J. 2004;24(5):758–764. https://doi.org/10.1183/09031936.04.00013904
  6. Sin B, Togias A. Pathophysiology of allergic and non-allergic rhinitis. Proc Am Thorac Soc. 2011;8(1):106–114. https://doi.org/10.1513/pats.201008-057RN
  7. Greiner AN, Hellings PW, Rotiroti G, Scadding GK. Allergic rhinitis. Lancet. 2011;378(9809):2112–2122. https://doi.org/10.1016/S0140-6736(11)60130-X
  8. Wise SK, Damask C, Roland LT, et al. International consensus statement on allergy and rhinology: Allergic rhinitis – 2023. Int Forum Allergy Rhinol. 2023;13(4): 293–859. https://doi.org/10.1002/alr.23090
  9. Brozek JL, Bousquet J, Baena-Cagnani CE, et al. Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines: 2010 revision. J Allergy Clin Immunol. 2010;126(3): 466–476. https://doi.org/10.1016/j.jaci.2010.06.047
  10. Walker S, Khan-Wasti S, Fletcher M, Cullinan P, Harris J, Sheikh A. Seasonal allergic rhinitis is associated with a detrimental effect on examination performance in United Kingdom teenagers: Case-control study. J Allergy Clin Immunol. 2007;120(2):381–387. https://doi.org/10.1016/j.jaci.2007.03.034
  11. Green RJ, Luyt DK. Clinical presentation of chronic non-infectious rhinitis in children. S Afr Med J. 1997;87(8):987–891.
  12. Schlosser RJ, Gage SE, Kohli P, Soler ZM. Burden of illness: A systematic review of depression in chronic rhinosinusitis. Am J Rhinol Allergy. 2016;30(4):250–256. https://doi.org/10.2500/ajra.2016.30.4343
  13. Thamrongsak C, Chirdkiatgumchai V, Jotikasthira W, Kiewngam P, Kanchongkittiphon W, Manuyakorn W. Improvement of inattentive and hyperactive symptoms after real-life rhinitis treatment in school-aged children. Int J Pediatr Otorhinolaryngol. 2022;157:111138. https://doi.org/10.1016/j.ijporl.2022.111138
  14. Lourenço O, Cvetkovski B, Kritikos V, et al. Management of allergic rhinitis symptoms in the pharmacy Pocket guide 2022. Clin Transl Allergy. 2022;12(10):e12183. https://doi.org/10.1002/clt2.12183
  15. Moitra S, Simoni M, Baldacci S, et al. Symptom control and health‐related quality of life in allergic rhinitis with and without comorbid asthma: A multicentre European study. Clin Transl Allergy. 2023;13(2):e12209. https://doi.org/10.1002/ clt2.12209
  16. Pawankar R. Allergic diseases and asthma: A global public health concern and a call to action. World Allergy Organ J. 2014;7:12. https://doi.org/10.1186/1939- 4551-7-12
  17. Brożek JL, Bousquet J, Agache I, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines – 2016 revision. J Allergy Clin Immunol. 2017;140(4):950–958. https://doi.org/10.1016/j.jaci.2017.03.050
  18. Fokkens WJ, Lund VJ, Hopkins C, et al. European position paper on rhinosinusitis and nasal polyps 2020. Rhinology. 2020;58(suppl. S29):1–464. https://doi.org/10.4193/Rhin20.600
  19. Hellings PW, Scadding G, Bachert C, et al. EUFOREA treatment algorithm for allergic rhinitis. Rhinology. 2020;58(6):618–622. https://doi.org/10.4193/Rhin20.376
  20. Kagee A. Treatment adherence in South African primary health care. S Afr Fam Prac. 2004;46(10):26–30. https://doi.org/10.1080/20786204.2004.10873151
  21. Seidman MD, Gurgel RK, Lin SY, et al. Clinical practice guideline: Allergic rhinitis. Otolaryngol Head Neck Surg. 2015;152(1 Suppl.):S1–43. https://doi.org/10.1177/0194599814561600
  22. Crystal-Peters J, Crown WH, Goetzel RZ, Schutt DC. The cost of productivity losses associated with allergic rhinitis. Am J Manag Care. 2000;6(3):373–378.
  23. Leung TF, Ko FW, Wong GW. Roles of pollution in the prevalence and exacerbations of allergic diseases in Asia. J Allergy Clin Immunol. 2012;129(1):42–47. https://doi.org/10.1016/j.jaci.2011.11.031
  24. D’Amato G, Akdis C. Global warming, climate change, air pollution and allergies. Allergy. 2020;75:2158–2160. https://doi.org/10.1111/all.14527
  25. Wise SK, Lin SY, Toskala E, et al. International consensus statement on allergy and rhinology: Allergic rhinitis. Int Forum Allergy Rhinol. 2018;8(2):108–352. https://doi.org/10.1002/alr.22073
  26. Van Gerven L, Steelant B, Hellings PW. Nasal hyperreactivity in rhinitis: A diagnostic and therapeutic challenge. Allergy. 2018;73(9):1784–1791. https://doi.org/10.1111/all.13453
  27. Demoly P, Urbinelli R, Allaert FA, Bousquet PJ. Should we modify the allergic rhinitis and its impact on asthma dichotomic classification of severity? Allergy. 2010;65:1488–1490. https://doi.org/10.1111/j.1398-9995.2010.02374.x
  28. Green RJ, Hockman M, Friedman R, et al. Chronic rhinitis in South Africa – More than just allergy! S Afr Med J. 2020;110(7):594–598. https://doi.org/10.7196/SAMJ.2020.v110i7.14553
  29. Green RJ, Hockman M, Friedman R, et al. Allergic rhinitis in South Africa: 2012 guidelines. S Afr Med J. 2012;102(8):693. https://doi.org/10.7196/SAMJ.5810
  30. Gray CL, Davis M, Friedman R, et al. The diagnosis and management of allergic rhinitis: Summary of recommendations by the South African Allergic Rhinitis Working Group (SAARWG) 2015. Curr Allergy Clin Immunol. 2015;28(4):285–295.
  31. Motala C, Hawarden D, on behalf of the Allergy Society of South Africa. Diagnostic testing in allergy. S Afr Med J. 2009;99(7):531–535. https://doi.org/10.7196/ SAMJ.3584
  32. Zeng G, Hu H, Zheng P. The practical benefit of Phadiatop test as the first-line in vitro allergen-specific immunoglobulin E (sIgE) screening of aeroallergens among Chinese asthmatics: A validation study. Ann Transl Med. 2018;6(8):151. https://doi.org/10.21037/atm.2018.04.06
  33. Esterhuizen N, Berman DM, Neumann FH, et al. The South African Pollen Monitoring Network: Insights from two years of 2 national aerospora sampling (2019–2021). Clin Transl Allergy. In press.
  34. Steven GC. Shared decision making in allergic rhinitis: An approach to the patient. Ann Allergy Asthma Immunol. 2020;125(3):268–272. https://doi.org/10.1016/j.anai.2020.06.032
  35. Blaiss MS, Steven GC, Bender B, Bukstein DA, Meltzer EO, Winders T. Shared decision making for the allergist. Ann Allergy Asthma Immunol. 2019;122(5): 463–470. https://doi.org/10.1016/j.anai.2018.08.019
  36. Levin ME. Education for allergic rhinitis. Curr Allergy Clin Immunol. 2014;27(2): 101–106.
  37. Kalayci O, Miligkos M, Pozo Beltrán CF, et al. The role of environmental allergen control in the management of asthma. World Allergy Organ J. 2022;15(3):100634. https://doi.org/10.1016/j.waojou.2022.100634
  38. Naidoo S. Environmental control of indoor allergens. Clin Immunol. 2019;32(1): 6–10.
  39. Nurmatov U, Schayck CP, Hurwitz B, Sheikh A. House dust mite avoidance measures for perennial allergic rhinitis: An updated Cochrane systematic review. Allergy. 2012;67(2):158–165. https://doi.org/10.1111/j.1398-9995.2011.02752.x
  40. Seedat RY. Environmental control of outdoor allergens. Curr Allergy Clin Immunol. 2019;32(1): 12–14.
  41. Head K, Snidvongs K, Glew S, et al. Saline irrigation for allergic rhinitis. Cochrane Database Syst Rev. 2018;6:CD012597. https://doi.org/10.1002/14651858.CD012597.pub2
  42. Am Acad Allergy Immunol. Saline sinus rinse recipe [homepage on the Internet]. [cited 2023 Oct 09]. Available from: https://www.aaaai.org/tools-for-the-public/conditions-library/allergies/saline-sinus-rinse-recipe.
  43. Seedat RY. Treatment of allergic rhinitis. Curr Allergy Clin Immunol. 2013;26(1):11–16.
  44. Sur DKC, Plesa ML. Treatment of allergic rhinitis. Allerg Rhinitis. 2015;92(11): 985–992.
  45. Daley-Yates PT. Inhaled corticosteroids: Potency, dose equivalence and therapeutic index. Br J Clin Pharmacol. 2015;80(3):372–380. https://doi.org/10.1111/ bcp.12637
  46. Lumry WR. A review of the preclinical and clinical data of newer intranasal steroids used in the treatment of allergic rhinitis. J Allergy Clin Immunol. 1999;104(4 Pt 1):S150–S158. https://doi.org/10.1016/s0091-6749(99)70311-8
  47. Derendorf H, Meltzer EO. Molecular and clinical pharmacology of intranasal corticosteroids: Clinical and therapeutic implications. Allergy. 2008;63(10): 1292–1300. https://doi.org/10.1111/j.1398-9995.2008.01750.x
  48. Benninger MS, Ahmad N, Marple BF. The safety of intranasal steroids. Otolaryngol Head Neck Surg. 2003;129(6):739–750. https://doi.org/10.1016/j.otohns.2003.10.001
  49. Corren J. Intranasal corticosteroids for allergic rhinitis: How do different agents compare? J Allergy Clin Immunol. 1999;104(4 Pt 1):S144–S149. https://doi.org/10.1016/s0091-6749(99)70310-6
  50. Weiner JM, Abramson MJ, Puy RM. Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: Systematic review of randomised controlled trials. BMJ. 1998;317(7173):1624–1629.
  51. Hox V, Lourijsen E, Jordens A, et al. Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis: An EAACI position paper. Clin Transl Allergy. 2020;10(1):1. https://doi.org/10.1186/s13601-019-0303-6
  52. Parisi GF, Leonardi S, Ciprandi G. Antihistamines in children and adolescents: A practical update. Allergol Immunopathol Madr. 2020;48(6):753–762. https://doi.org/10.1016/j.aller.2020.02.005
  53. Fein MN, Fischer DA, O’Keefe AW, Sussman GL. CSACI position statement: Newer generation H1-antihistamines are safer than first-generation H1-antihistamines and should be the first-line antihistamines for the treatment of allergic rhinitis and urticaria. Allergy Asthma Clin Immunol. 2019;15(1):61. https://doi.org/10.1186/s13223-019-0375-9
  54. Kawauchi H, Yanai K, Wang D-Y, Itahashi K, Okubo K. Antihistamines for allergic rhinitis treatment from the viewpoint of nonsedative properties. Int J Mol Sci. 2019;20(1):213. https://doi.org/10.3390/ijms20010213
  55. Mullol J, Bousquet J, Bachert C, et al. Rupatadine in allergic rhinitis and chronic urticaria. Allergy. 2008;63(s87):5–28. https://doi.org/10.1111/j.1398-9995.2008.01640.x
  56. Miligkos M, Dakoutrou M, Statha E. Newer-generation antihistamines and the risk of adverse events in children: A systematic review. Pediatr Allergy Immunol. 2021;32(7):1533–1558. https://doi.org/10.1111/pai.13522
  57. Scadding GK, Smith PK, Blaiss M, et al. Allergic rhinitis in childhood and the new EUFOREA algorithm. Front Allergy. 2021;2:706589. https://doi.org/10.3389/falgy.2021.706589
  58. Shah S. Effects of olopatadine hydrochloride nasal spray 0.6% in the treatment seasonal allergic rhinitis. Clin Ther. 2009;31(1):99–107. https://doi.org/10.1016/j.clinthera.2009.01.016
  59. Feng Y, Meng Y-P, Dong Y-Y, Qiu C-Y, Cheng L. Management of allergic rhinitis with leukotriene receptor antagonists versus selective H1-antihistamines: A metaanalysis of current evidence. Allergy Asthma Clin Immunol. 2021;17(1):62. https://doi.org/10.1186/s13223-021-00564-z
  60. Lalloo UG, Kalla IS, Abdool-Gaffar S. on behalf of the Asthma Working Group of the South African Thoracic Society. Guidelines for the management of asthma in adults and adolescents: Position statement of the South African Thoracic Society – 2021 update. Afr J Thorac Crit Care Med. 2021;27(4):187–199. https://doi.org/10.7196/AJTCCM.2021.v27i4.189
  61. Gupta SK, Kantesaria B, Banfield C, Wang Z. Desloratadine dose selection in children aged 6 months to 2 years: Comparison of population pharmacokinetics between children and adults. Br J Clin Pharmacol. 2007;64(2):174–184. https://doi.org/10.1111/j.1365-2125.2007.02859.x
  62. Hampel FC, Kittner B, Bavel JH. Safety and tolerability of fexofenadine hydrochloride, 15 and 30 mg, twice daily in children aged 6 months to 2 years with allergic rhinitis. Ann Allergy Asthma Immunol. 2007;99(6):549–554. https://doi.org/10.1016/S1081-1206(10)60385-7
  63. Drazdauskaitė G, Layhadi JA, Shamji MH. Mechanisms of allergen immunotherapy in allergic rhinitis. Curr Allergy Asthma Rep. 2021;21(1):2. https://doi.org/10.1007/s11882-020-00977-7
  64. Boonpiyathad T, Lao-Araya M, Chiewchalermsri C. Allergic rhinitis: What do we know about allergen-specific immunotherapy? Front Allergy. 2021;2:747323. https://doi.org/10.3389/falgy.2021.747323
  65. Jacobsen L, Niggemann B, Dreborg S. Specific immunotherapy has long term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study. Allergy. 2007;62(8):943–948. https://doi.org/10.1111/j.1398-9995. 2007.01451.x
  66. Radulovic S, Wilson D, Calderon M, Durham S. Systematic reviews of sublingual immunotherapy (SLIT). Allergy. 2011;66(6):740–752. https://doi.org/10.1111/j.1398-9995.2011.02583.x
  67. Fritzsching B, Contoli M, Porsbjerg C, et al. Long-term real-world effectiveness of allergy immunotherapy in patients with allergic rhinitis and asthma: Results from the REACT study, a retrospective cohort study. Lancet Reg Health – Eur. 2022;13:100275. https://doi.org/10.1016/j.lanepe.2021.100275
  68. Bousquet J, Pfaar O, Agache I, et al. ARIA-EAACI care pathways for allergen immunotherapy in respiratory allergy. Clin Transl Allergy. 2021;11(4):e12014. https://doi.org/10.1002/clt2.12014
  69. Durham SR, Shamji MH. Allergen immunotherapy: Past, present and future. Nat Rev Immunol. 2023;23(5):317–328. https://doi.org/10.1038/s41577-022-00786-1
  70. Alvaro-Lozano M, Akdis CA, Akdis M. EAACI Allergen Immunotherapy User’s Guide. Pediatr Allergy Immunol. 2020;31(suppl. 25):1–101. https://doi.org/10.1111/pai.13189
  71. Liess BD. Immunotherapy for allergies technique. Updated [homepage on the Internet] [cited 2023 Oct 09]. Available from: https://emedicine.medscape.com/article/1588289-print
  72. Rouve S, Didier A, Demoly P. Numeric score and visual analog scale in assessing seasonal allergic rhinitis severity. Rhinology. 2010;48(3):285–291. https://doi.org/10.4193/Rhino09.208
  73. Klimek L, Bergmann K-C, Biedermann T, et al. Visual analogue scales (VAS): Measuring instruments for the documentation of symptoms and therapy monitoring in cases of allergic rhinitis in everyday health care: Position Paper of the German Society of Allergology (AeDA) and the German Society of Allergy and Clinical Immunology (DGAKI), ENT Section, in collaboration with the working group on Clinical Immunology, Allergology and Environmental Medicine of the German Society of Otorhinolaryngology, Head and Neck Surgery (DGHNOKHC). Allergo J Int. 2017;26(1):16–24. https://doi.org/10.1007/s40629- 016-0006-7
  74. Qoltech – Measurement of health-related quality of life & asthma control [homepage on the Internet]. [cited 2023 Sept 10]. Available from: http://www.qoltech.co.uk/language_lists.html#rqlq
  75. Cheng L, Chen J, Fu Q. Chinese Society of Allergy guidelines for diagnosis and treatment of allergic rhinitis. Allergy Asthma Immunol Res. 2018;10(4):300–353. https://doi.org/10.4168/aair.2018.10.4.30
  76. Lee J-C, Kao C-H, Hsu C-H, Lin Y-S. Endoscopic transsphenoidal vidian neurectomy. Euro Arch Otorhinolaryngol. 2011;268(6):851–856. https://doi.org/10.1007/s00405-010-1482-x
  77. Alsharif S, Jonstam K, Zele T. Endoscopic sinus surgery for type-2 CRS wNP: An endotype-based retrospective study. Laryngoscope. 2019;129(6):1286–1292. https://doi.org/10.1002/lary.27815
  78. Gelardi M, Giancaspro R, Bocciolini C. Turbinate surgery: Which rhinitis are most at risk. Acta Biomed. 2022;93(4). https://doi.org/10.23750/abm.v93i4.12200
  79. Hellings PW, Fokkens WJ, Bachert C, et al. Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis – A EUFOREA-ARIA-EPOS-AIRWAYS ICP statement. Allergy. 2017;72(9):1297–1305. https://doi.org/10.1111/all.13162
  80. Cingi C, Gevaert P, Mösges R. Multi-morbidities of allergic rhinitis in adults: European Academy of Allergy and Clinical Immunology Task Force Report. Clin Transl Allergy. 2017;7:17. https://doi.org/10.1186/s13601-017-0153-z

Click here to access the PDF.

Richards GA, McDonald M, Gray CL, et al. Allergic rhinitis: Review of the diagnosis and management: South African Allergic Rhinitis Working Group. S Afr Fam Pract. 2023;65(1), a5806. https://doi.org/10.4102/safp.v65i1.5806

Drugs mentioned

NeoHealth® ID 36273 · updated 4/23/2024